References
- Ahrendsen, J. T., Ta, R., Li, J., Weinberg, O. K., Ferry, J. A., Hasserjian, R. P., Meredith, D. M., Varma, H., Sadigh, S., & Michaels, P. D. (2022). Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK Positive. American journal of clinical pathology, 158(2), 300–310.
https://doi.org/10.1093/ajcp/aqac046 . - Nomura, M., Narita, Y., Miyakita, Y., Ohno, M., Fukushima, S., Maruyama, T., Muragaki, Y., & Shibui, S. (2013). Clinical presentation of anaplastic large-cell lymphoma in the central nervous system. Molecular and clinical oncology, 1(4), 655–660.
https://doi.org/10.3892/mco.2013.110 . - Salzburg J, Burkhardt B, Zimmermann M, Wachowski O, Woessmann W, Oschlies I, et al. Prevalence, clinical pattern, and outcome of CNS involve ment in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report. J Clin Oncol. 2007;25:3915–22.
- Brugieres L, Le Deley MC, Rosolen A, Williams D, Horibe K, Wrobel G, et al. Impact of the Methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group. J Clin Oncol. 2009;27:897–903.
- H Stein, H D Foss, H Durkop, T Marafioti, G Delsol, K Pulford, S Pileri and B Falini: CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood, 96(12), 3681–3695 (2000).
- S W Morris, M N Kirstein, M B Valentine, K G Dittmer, D N Shapiro, D L Saltman and A T Look: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science, 263(5151), 1281–4 (1994) DOI: 10.1126/science.8122112.
- Vose JM, Neumann M, Harris ME. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes international T-cell lymphoma project. J Clin Oncol 2008;26(25):4124–30.
- Young RF, Post EM, King GA. Treatment of spinal epidural metastases. Randomized prospective comparison of laminectomy and radiotherapy. J Neurosurg 1980;53(6):741–8.
- Dong X, Li J, Huo N, et al. Primary central nervous system ALK-positive anaplastic large cell lymphoma in an adult. Medicine. 2016;95:e5534.
- Wang, C. X., Wang, H., Li, J., Ma, H. H., Yu, B., Shi, S. S., Zhou, X. J., & Shi, Q. L. (2014). Brain metastasis of ALK positive anaplastic large cell lymphoma after a long-term disease free survival in an old adult. International journal of clinical and experimental pathology, 7(3), 1182–1187.
- Kim, M.K.; Cho, C.H.; Sung, W.J.; Ryoo, H.M.; Lee, H.J.; Youn, S.W.; Park, K.K. Primary Anaplastic Large Cell Lymphoma in the Dura of the Brain: Case Report and Prediction of a Favorable Prognosis. Int. J. Clin. Exp. Pathol. 2013, 6, 1643–1651.
- Kodama, K.; Hokama, M.; Kawaguchi, K.; Tanaka, Y.; Hongo, K. Primary ALK-1-Negative Anaplastic Large Cell Lymphoma of the Brain: Case Report and Review of the Literature. Neuropathology 2009, 29, 166–171.
- Sugino, T.; Mikami, T.; Akiyama, Y.; Wanibuchi, M.; Hasegawa, T.; Mikuni, N. Primary Central Nervous System Anaplastic Large-Cell Lymphoma Mimicking Lymphomatosis Cerebri. Brain Tumor Pathol. 2013, 30, 61–65.
- Zhang, X., Bui, M. M., Caracciolo, J., Field, T. L., & Zhang, L. (2011). Adult anaplastic large cell lymphoma involving the central nervous system: a rare clinical scenario. Annals of hematology, 90(6), 721–723.
https://doi.org/10.1007/s00277-010-1074-2 . - Carmichael M. G. (2007). Central nervous system anaplastic large cell lymphoma in an adult: successful treatment with a combination of radiation and chemotherapy. Military medicine, 172(6), 673–675.
https://doi.org/10.7205/milmed.172.6.673 . - Vivekanandan, S.; Dickinson, P.; Bessell, E.; O'Connor, S. An Unusual Case of Primary Anaplastic Large Cell Central Nervous System Lymphoma: An 8-Year Success Story. BMJ Case. Rep. 2011, 2011, bcr1120103550.
- Karikari, I.O.; Thomas, K.K.; Lagoo, A.; Cummings, T.J.; George, T.M. Primary Cerebral ALK-1-Positive Anaplastic Large Cell Lymphomain aChild. Case Report and Literature Review. Pediatr. Neurosurg. 2007, 43, 516–521.
- Ponzoni, M.; Terreni, M.R.; Ciceri, F.; Ferreri, A.J.; Gerevini, S.; Anzalone, N.; Valle, M.; Pizzolito, S.; Arrigoni, G. Primary brain CD30+ALK1+anaplastic large cell lymphoma (‘ALKoma’): The first case with a combination of ‘not common’ variants. Ann. Oncol. 2002, 13, 1827–1832.
- George, D.H.; Scheithauer, B.W.; Aker, F.V.; Kurtin, P.J.; Burger, P.C.; Cameselle-Teijeiro, J.; McLendon, R.E.; Parisi, J.E.; Paulus, W.; Roggendorf, W.; et al. Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: Prognostic Effect of ALK-1 Expression. Am. J. Surg. Pathol. 2003, 27, 487–493.
- Merlin, E.; Chabrier, S.; Verkarre, V.; Cramer, E.; Delabesse, E.; Stéphan, J.L. Primary Leptomeningeal ALK+ Lymphoma in a 13-Year-Old Child. J. Pediatr. Hematol. Oncol. 2008, 30, 963–967.
- Ozkaynak, M.F. Favorable Outcome of Primary CNS Anaplastic Large Cell Lymphoma in an Immunocompetent Patient. J. Pediatr. Hematol. Oncol. 2009, 31, 128–130.
- Shah, A.C.; Kelly, D.R.; Nabors, L.B.; Oakes, W.J.; Hilliard, L.M.; Reddy, A.T. Treatment of Primary CNS Lymphoma with High-Dose Methotrexate in Immunocompetent Pediatric Patients. Pediatr. Blood Cancer 2010, 55, 1227–1230.
- Park, J.S.; Park, H.; Park, S.; Kim, S.J.; Seol, H.J.; Ko, Y.H. Primary Central Nervous System ALK Positive Anaplastic Large Cell Lymphomawith Predominantly Leptomeningeal Involvement in an Adult. Yonsei Med. J. 2013, 54, 791–796.
- Dunbar, M.J.; Singhal, A.; Rassekh, S.R.; Dunham, C. Evolution of a Pediatric Primary Cerebral ALK-1-Positive Anaplastic Large Cell Lymphoma on Serial MRI. Pediatr. Neurosurg. 2015, 50, 145–151.
- Kuntegowdenahalli, L.C.; Jacob, L.A.; Komaranchath, A.S.; Amirtham, U. A Rare Case of Primary Anaplastic Large Cell Lymphomaof the Central Nervous System. J. Cancer Res. Ther. 2015, 11, 943–945.
- Kaku, M.V.; Savardekar, A.R.; Muthane, Y.; Arivazhagan, A.; Rao, M.B. Primary Central Nervous System Dural-Based Anaplastic Large Cell Lymphoma: Diagnostic Considerations, Prognostic Factors, and Treatment Modalities. Neurol. India 2017, 65, 402–405.
- Feng, S.; Chen, Q.; Chen, J.; Zheng, P.; Ma, K.; Tan, B. Primary Anaplastic Large Cell Lymphoma of the Central Nervous System in a Child: A Case Report. Medicine 2020, 99, e21115.
- Liu, Q.; Chen, X.; Li, G.; Ye, Y.; Liu, W.; Zhao, S.; Zhang, W. Primary Central Nervous System ALK-Positive Anaplastic Large Cell Lymphoma with CD56 Abnormally Expression in a Chinese Child: Challenge in Diagnostic Practice. Int. J. Immunopathol. Pharmacol. 2020, 34, 2058738420941756.
- El Farissi, M. A. A., Dehneh, Y., Kada, A., Dahamou, M., Khoulali, M., Oulali, N., & Moufid, F. (2023). Uncommon spinal involvement of ALK-positive anaplastic large cell lymphoma: A pediatric case report and literature review. Radiology case reports, 19(1), 341–345.
https://doi.org/10.1016/j.radcr.2023.10.018 . - Verran, J., & Mathavan, V. (2022). Alectinib Monotherapy in Isolated Central Nervous System Relapse of ALK-Positive Anaplastic Large Cell Lymphoma. Case reports in hematology, 2022, 4749452.
https://doi.org/10.1155/2022/4749452 . - Brady, A. L., Fuller, C. E., Patel, S., Hall, W., Banki, K., & Ghimire, K. B. (2023). Primary CNS ALK-negative anaplastic large cell lymphoma: A case report and review of the literature. Radiology case reports, 19(1), 393–399.
https://doi.org/10.1016/j.radcr.2023.09.095 . - Lee, S.W.; Jung, T.Y.; Baek, H.J.; Kim, S.K.; Lee, K.H. Dural-Based Primary Central Nervous System Lymphoma with Bone Invasion. World Neurosurg. 2020, 139, 415–418.
- Omae Ryo, Kohno Shohei, Shinko Aiko, Takeru Asano, Kazuya Takahashi, A case of primary central nervous system anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the neurohypophysis and pineal gland, Interdisciplinar Neurosurgery, Volume 30, 2022, 101611, ISSN 2214-7519,
https://doi.org/10.1016/j.inat.2022.101611 . - Strosberg C, Sagatys EM. Primary anaplastic large cell lymphoma of the CNS as initial presentation of HIV infection: a case report. Hum Pathol Case Rep. 2021;24:200513.
- Lannon, M.; Lu, J.Q.; Chum, M.; Wang, B.H. ALK-Negative CNS Anaplastic Large Cell Lymphoma: Case Report and Review of Literature. Br. J. Neurosurg. 2020, 30, 1–6.
- Nomura, M., Narita, Y., Miyakita, Y., Ohno, M., Fukushima, S., Maruyama, T., Muragaki, Y., & Shibui, S. (2013). Clinical presentation of anaplastic large-cell lymphoma in the central nervous system. Molecular and clinical oncology, 1(4), 655–660.
https://doi.org/10.3892/mco.2013.110 . - Hirano, Y.; Miyawaki, S.; Tanaka, S.; Taoka, K.; Hongo, H.; Teranishi, Y.; Takami, H.; Takayanagi, S.; Kurokawa, M.; Saito, N. Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphomaof the Central Nervous System: A Systematic Review. Cancers 2021, 13, 4358.
https://doi.org/10.3390/cancers13174358 . - Rupani, A.; Modi, C.; Desai, S.; Rege, J. Primary Anaplastic Large Cell Lymphoma of Central Nervous System—A Case Report. J. Postgrad. Med. 2005, 51, 326–327.
- Grommes, C.; Rubenstein, J.L.; DeAngelis, L.M.; Ferreri, A.J.M.; Batchelor, T.T. Comprehensive Approach to Diagnosis and Treatment of Newly Diagnosed Primary CNS Lymphoma. Neuro-Oncology 2019, 21, 296–305.
- Suzuki R, Kagami Y, Takeuchi K, et al: Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype. Blood 96: 2993–3000, 2000.
- Tsuyama, N.; Sakamoto, K.; Sakata, S.; Dobashi, A.; Takeuchi, K. Anaplastic Large Cell Lymphoma: Pathology, Genetics, and Clinical Aspects. J. Clin. Exp. Hematop. 2017, 57, 120–142.
- Batchelor, T.; Carson, K.; O'Neill, A.; Grossman, S.A.; Alavi, J.; New, P.; Hochberg, F.; Priet, R. Treatment of Primary CNS Lymphoma with Methotrexate and Deferred Radiotherapy: A Report of NABTT 96-07. J. Clin. Oncol. 2003, 21, 1044–1049.
- Y. Kim, A. Sudo, R. Oyama et al., “Isolated central nervous system progression during systemic treatment with bren tuximab vedotin monotherapy in a pediatric patient with recurrent ALK-negative anaplastic large cell lymphoma,” Journal of Pediatric Hematology, vol. 43, no. 6, pp. e864–e866, 2020.